DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC HOG003 A549 24H F05 PRL-3-inhibitor-I 1.11um.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

A549

Subject (Entity type)

Project:

L1000-Phase1

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Disease:

lung cancer

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC HOG003 A549 24H F05 PRL-3-inhibitor-I 1.11um

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

lung

Anatomy (Entity type)

Uncompressed Size In Bytes:757 KB

Size In Bytes:279 KB

Sha256:e2fd4ace7c2f074ab9e50f9d178ee5775af3d9077654894f885dbb0e98be51f6

Persistent Id:drs://drs.lincs-dcic.org/925d175f375ed929ee3977c633dd96ed

Mime Type:application/gzip

Md5:925d175f375ed929ee3977c633dd96ed

Filename:L1000_LINCS_DCIC_HOG003_A549_24H_F05_PRL-3-inhibitor-I_1.11um.tsv.gz

Creation Time:2017-03-03T00:00:00

Access Url:

drs://drs.lincs-dcic.org/925d175f375ed929ee3977c633dd96ed

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC HOG003 A549 24H F05 PRL-3-inhibitor-I 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC HOG003 A549 24H F05 PRL-3-inhibitor-I 1.11um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.